Document is current
Any future updates will be listed below
-
Authors
Tong, Yan
Tonui, Philip
Orang’o, Omenge
Zhang, Jianjun
Maina, Titus
Muthoka, Kapten
Groopman, John
Smith, Joshua
Madeen, Erin
Ermel, Aaron
Loehrer, Patrick
Brown, Darron R.
-
Funding
Funding for this research was provided by:
National Cancer Institute, United States (1U54CA190151-01, 1U54CA190151-01, 1U54CA190151-01, P30 CA082709, 1U54CA190151-01, 1U54CA190151-01, P30 CA082709, P30 CA082709, P30 CA082709, 1U54CA190151-01, 1U54CA190151-01, 1U54CA190151-01)
- License Information
-
More Information
Article History
Received: 11 January 2023
Accepted: 11 May 2023
First Online: 6 June 2023
Declarations
:
: Study approval was granted from the local review board at Moi Teaching and Referral Hospital (MTRH) and Moi University, Eldoret, Kenya, the Kenya Medical Research Institute’s Scientific and Ethics Review Unit (KEMRI-SERU) and the Institutional Review Board of Indiana University. All participants provided written informed consent, either in Swahili or English, for participation in the study and for use of clinical specimens. All study procedures were performed in accordance with relevant guidelines and regulations outlined by the Ethics Review Boards indicated above.
: Not applicable.
: Dr. Brown currently receives research funding and has received royalties and consulting fees in the past from Merck and Co., Inc. Dr. Brown serves on the Scientific Advisory Board for PDS, Inc.The other Authors do not possess any potential conflicts of interest.
